MethHC 2.0: information repository of DNA methylation and gene expression in human cancer

Abstract DNA methylation is an important epigenetic regulator in gene expression and has several roles in cancer and disease progression. MethHC version 2.0 (MethHC 2.0) is an integrated and web-based resource focusing on the aberrant methylomes of human diseases, specifically cancer. This paper presents an updated implementation of MethHC 2.0 by incorporating additional DNA methylomes and transcriptomes from several public repositories, including 33 human cancers, over 50 118 microarray and RNA sequencing data from TCGA and GEO, and accumulating up to 3586 manually curated data from >7000 collected published literature with experimental evidence. MethHC 2.0 has also been equipped with enhanced data annotation functionality and a user-friendly web interface for data presentation, search, and visualization. Provided features include clinical-pathological data, mutation and copy number variation, multiplicity of information (gene regions, enhancer regions, and CGI regions), and circulating tumor DNA methylation profiles, available for research such as biomarker panel design, cancer comparison, diagnosis, prognosis, therapy study and identifying potential epigenetic biomarkers. MethHC 2.0 is now available at http://awi.cuhk.edu.cn/∼MethHC.

[1]  Alexander V. Favorov,et al.  Differentially Methylated Super-Enhancers Regulate Target Gene Expression in Human Cancer , 2019, Scientific Reports.

[2]  Yixue Li,et al.  Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers , 2018, Genome Medicine.

[3]  B. Baradaran,et al.  Scrophularia Atropatana Extract Reverses TP53 Gene Promoter Hypermethylation and Decreases Survivin Antiapoptotic Gene Expression in Breast Cancer Cells , 2018, Asian Pacific journal of cancer prevention : APJCP.

[4]  Adrian V. Lee,et al.  An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics , 2018, Cell.

[5]  N. Capalash,et al.  Curcumin causes promoter hypomethylation and increased expression of FANCF gene in SiHa cell line , 2012, Molecular and Cellular Biochemistry.

[6]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..

[7]  P. Peltomäki,et al.  MicroRNA Methylation in Colorectal Cancer. , 2016, Advances in experimental medicine and biology.

[8]  Gangning Liang,et al.  Gene body methylation can alter gene expression and is a therapeutic target in cancer. , 2014, Cancer cell.

[9]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[10]  Andreas Rimner,et al.  MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. , 2011, Genes & development.

[11]  Daria A. Gaykalova,et al.  Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers , 2019, Nature Communications.

[12]  David Haussler,et al.  UCSC Genome Browser enters 20th year , 2019, Nucleic Acids Res..

[13]  L. Vrba,et al.  DNA methylation changes in biomarker loci occur early in cancer progression , 2019, F1000Research.

[14]  Tae-Wook Kang,et al.  MENT: methylation and expression database of normal and tumor tissues. , 2013, Gene.

[15]  P. M. Das,et al.  DNA methylation and cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Ehrlich.  DNA hypermethylation in disease: mechanisms and clinical relevance , 2019, Epigenetics.

[17]  Hsien-Da Huang,et al.  MethHC: a database of DNA methylation and gene expression in human cancer , 2014, Nucleic Acids Res..

[18]  Andrew P. Feinberg,et al.  Genome-scale approaches to the epigenetics of common human disease , 2009, Virchows Archiv.

[19]  M. Lacey,et al.  DNA hypomethylation and hemimethylation in cancer. , 2013, Advances in experimental medicine and biology.

[20]  Yingdong Zhao,et al.  MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer , 2010, Clinical Cancer Research.

[21]  I. Ng,et al.  Epigenetic repression of E-cadherin expression by Hepatitis B virus x Antigen (HBx) in liver cancer , 2011, Oncogene.

[22]  Bin Zhang,et al.  DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database , 2016, Nucleic Acids Res..

[23]  R. Agami,et al.  Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer , 2010, Molecular Cancer.

[24]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[25]  M. Kanda,et al.  Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma. , 2018, Oncology reports.

[26]  X. Bian,et al.  The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2 , 2011, Gut.

[27]  Jie Lv,et al.  DiseaseMeth: a human disease methylation database , 2011, Nucleic Acids Res..

[28]  R. Weinberg,et al.  Tumor suppressor genes. , 1991, Science.

[29]  Gabriel Capellá,et al.  DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer , 2013, Cancer Prevention Research.

[30]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[31]  P. Georgel,et al.  The epigenetic potentials of dietary polyphenols in prostate cancer management. , 2013, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[32]  Tzong-Yi Lee,et al.  Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data , 2011, Nucleic acids research.

[33]  Jiajie Zhang,et al.  MethyCancer: the database of human DNA methylation and cancer , 2007, Nucleic Acids Res..

[34]  Martha R. Stampfer,et al.  miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer , 2013, PloS one.

[35]  Yuh Shiwa,et al.  iMETHYL: an integrative database of human DNA methylation, gene expression, and genomic variation , 2018, Human Genome Variation.

[36]  R. Siebert,et al.  Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. , 2009, Cancer research.

[37]  G. Calin,et al.  Non-coding RNAs in Colorectal Cancer , 2016, Advances in Experimental Medicine and Biology.

[38]  Tim De Meyer,et al.  Analysis of DNA methylation in cancer: location revisited , 2018, Nature Reviews Clinical Oncology.

[39]  G. Samimi,et al.  Methylated circulating tumor DNA in blood: power in cancer prognosis and response , 2016, Endocrine-related cancer.

[40]  Éric Renault,et al.  MethDB - a public database for DNA methylation data , 2001, Nucleic Acids Res..

[41]  Mengwei Li Campbell,et al.  MethBank 3.0: a database of DNA methylomes across a variety of species , 2017, Nucleic Acids Res..

[42]  D. Bourc’his,et al.  The diverse roles of DNA methylation in mammalian development and disease , 2019, Nature Reviews Molecular Cell Biology.

[43]  Jiang Qian,et al.  EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue/cell types across nine species , 2019, Nucleic Acids Res..

[44]  Michael Hackenberg,et al.  NGSmethDB 2017: enhanced methylomes and differential methylation , 2016, Nucleic Acids Res..

[45]  A. Karpf.  Epigenetic Alterations in Oncogenesis , 2013, Advances in Experimental Medicine and Biology.

[46]  Michael Hackenberg,et al.  NGSmethDB: a database for next-generation sequencing single-cytosine-resolution DNA methylation data , 2010, Nucleic Acids Res..

[47]  U. Lehmann.  Aberrant DNA methylation of microRNA genes in human breast cancer – a critical appraisal , 2014, Cell and Tissue Research.

[48]  Gerben Menschaert,et al.  PubMeth: a cancer methylation database combining text-mining and expert annotation , 2007, Nucleic Acids Res..

[49]  A. Bal,et al.  BRCA1-methylated sporadic breast cancers are BRCA-like in showing a basal phenotype and absence of ER expression , 2012, Virchows Archiv.

[50]  A. Maunakea,et al.  High-throughput sequencing offers new insights into 5-hydroxymethylcytosine , 2016, Biomolecular concepts.